Literature DB >> 9776849

Fibroblast senescence in pressure ulcers.

J S Vande Berg1, R Rudolph, C Hollan, P L Haywood-Reid.   

Abstract

Pressure ulcers appear as localized chronic wounds in the middle of normal functioning skin. This study focuses on pressure ulcer fibroblasts cultured from the ulcer bed, ulcer margin, and normal, nonulcerated skin adjacent to the wound. From these areas we show that pressure ulcer fibroblasts become prematurely senescent. Verification of senescence was based on failure of cell populations to undergo a 0.5 population doubling after 1 week in culture, light microscopic appearance of late-passage senescent cells in culture, light microscopic verification of senescence in vivo and in vitro by anti-terminin staining, and ultrastructural identification of senescent fibroblasts by anti-terminin colloidal gold labeling. Although not all ulcer fibroblasts are senescent, there is a range of proliferative ability. The senescent phenotype of ulcer fibroblasts remains intact in vitro as these cells remain viable but are unable to complete DNA synthesis. Fibroblast senescence is not uniform in chronic wounds but varies within areas of the ulcer bed and from patient to patient. Although ulcer fibroblasts exhibit limited proliferative ability, fibroblasts from the ulcer margin and adjacent normal skin show a continued ability to divide. However, in all areas of the wound, the mean generation time of the fibroblast population is longer than commonly observed for cultured human diploid fibroblasts. At first passage, the mean generation time for fibroblasts from all patients is significantly different (p = .001, analysis of variance) among fibroblasts from the ulcer bed (4.2 2.2 days), ulcer margin (2.9 +/- 1.3 days), and adjacent normal skin (1.9 +/- 0.6 days). Analysis of the three cell groups by the post hoc Tukey test, using corrected p values shows that the difference between mean generation times among fibroblast populations from adjacent normal skin and ulcer bed are significantly different (p < 0.05), whereas the difference between fibroblasts from adjacent normal skin and ulcer margin and ulcer margin and ulcer bed are not significantly different (p > 0.05). These data may help to explain the poor response of certain pressure sores to aggressive medical treatment.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9776849     DOI: 10.1046/j.1524-475x.1998.60107.x

Source DB:  PubMed          Journal:  Wound Repair Regen        ISSN: 1067-1927            Impact factor:   3.617


  24 in total

Review 1.  Chemokines in Wound Healing and as Potential Therapeutic Targets for Reducing Cutaneous Scarring.

Authors:  Peter Adam Rees; Nicholas Stuart Greaves; Mohamed Baguneid; Ardeshir Bayat
Journal:  Adv Wound Care (New Rochelle)       Date:  2015-11-01       Impact factor: 4.730

Review 2.  Chemokines as Therapeutic Targets to Improve Healing Efficiency of Chronic Wounds.

Authors:  Latha Satish
Journal:  Adv Wound Care (New Rochelle)       Date:  2015-11-01       Impact factor: 4.730

Review 3.  Wound bed preparation and a brief history of TIME.

Authors:  Gregory S Schultz; David J Barillo; David W Mozingo; Gloria A Chin
Journal:  Int Wound J       Date:  2004-04       Impact factor: 3.315

Review 4.  Tissue engineering of replacement skin: the crossroads of biomaterials, wound healing, embryonic development, stem cells and regeneration.

Authors:  Anthony D Metcalfe; Mark W J Ferguson
Journal:  J R Soc Interface       Date:  2007-06-22       Impact factor: 4.118

5.  The use of marrow-derived stem cells to accelerate healing in chronic wounds.

Authors:  Lee C Rogers; Nicholas J Bevilacqua; David G Armstrong
Journal:  Int Wound J       Date:  2008-01-03       Impact factor: 3.315

6.  Exogenous growth factors enhance the expression of cola1, cola3, and Elastin in fibroblasts via activating MAPK signaling pathway.

Authors:  TianDing Shen; Kai Gao; Yong Miao; ZhiQi Hu
Journal:  Mol Cell Biochem       Date:  2017-11-28       Impact factor: 3.396

7.  Sequential cytokine therapy for pressure ulcers: clinical and mechanistic response.

Authors:  M C Robson; D P Hill; P D Smith; X Wang; K Meyer-Siegler; F Ko; J S VandeBerg; W G Payne; D Ochs; L E Robson
Journal:  Ann Surg       Date:  2000-04       Impact factor: 12.969

8.  Autologous Bone Marrow Aspirate Therapy in Wound Healing.

Authors:  Ravi Kumar Chittoria; Vijayaraghavan Nandhagopal; Devi Prasad Mohapatra; Friji Meethale Thiruvoth; Dinesh Kumar Sivakumar; Arjun Asokan
Journal:  Adv Wound Care (New Rochelle)       Date:  2016-03-01       Impact factor: 4.730

Review 9.  Molecular Mechanisms and Potential Therapeutic Targets in Incisional Hernia.

Authors:  Finosh G Thankam; Gunasekar Palanikumar; Robert J Fitzgibbons; Devendra K Agrawal
Journal:  J Surg Res       Date:  2018-12-14       Impact factor: 2.192

Review 10.  The biology of hernia formation.

Authors:  Michael G Franz
Journal:  Surg Clin North Am       Date:  2008-02       Impact factor: 2.741

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.